Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 6/20 | 0.48 |
| ▸ | SFRP1 | Q8N474 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 4/20 | 0.40 |
| ▸ | HTR1A | P08908 | 4/20 | 0.40 |
| ▸ | DRD2 | P14416 | 4/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | HTR1B | P28222 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6735097 | 0.93 | HTR7 (0.46) | HTR7SFRP1HTR2AHTR1ADRD2 | |
| SCHEMBL6098357 | 0.81 | HTR7 (0.47) | HTR7SFRP1HTR2AHTR1ADRD2 | |
| Hydrochloric Acid SCHEMBL6096966 | 0.80 | HTR7 (0.46) | HTR7SFRP1HTR2AHTR1ADRD2 | |
| SCHEMBL6098060 | 0.79 | HTR7 (0.60) | HTR7SFRP1HTR2ADRD2KCNH2 | |
| SCHEMBL6096555 | 0.76 | HTR7 (0.52) | HTR7SFRP1HTR2AHTR1ADRD2 | |
| SCHEMBL6097772 | 0.75 | HTR7 (0.50) | HTR7HTR2AHTR1ADRD2KCNH2 | |
| SCHEMBL6097225 | 0.75 | HTR7 (0.52) | HTR7HTR2ADRD2KCNH2HTR2C | |
| SCHEMBL6097623 | 0.74 | HTR7 (0.57) | HTR7SFRP1HTR2AHTR1ADRD2 | |
| SCHEMBL19248406 | 0.67 | PSIP1 (0.56) | MEN1KMT2A | |
| SCHEMBL6098365 | 0.67 | HTR7 (0.40) | HTR7CCR5KMT2ANR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101892-B2 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. | 2006-09-05 | — | — | US | disclosed |
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | HTR7, HTR2C, HTR1A | HTR7 1/4885SFRP1 1633/4885HTR2A 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.